Search Results - "Picod, Adrien"
-
1
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
Published in Blood (21-04-2022)Get full text
Journal Article -
2
Electrical impedance tomography: the solution for lung morphology assessment?
Published in Annals of intensive care (03-08-2020)Get full text
Journal Article -
3
Deregulated JAK3 mediates growth advantage and hemophagocytosis in extranodal nasal-type natural killer/T cell lymphoma
Published in Haematologica (Roma) (01-09-2022)Get full text
Journal Article -
4
Impaired angiotensin II signaling in septic shock
Published in Annals of intensive care (14-06-2024)“…Recent years have seen a resurgence of interest for the renin–angiotensin–aldosterone system in critically ill patients. Emerging data suggest that this vital…”
Get full text
Journal Article -
5
Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study
Published in Frontiers in immunology (12-05-2022)“…The prognostic impact of high concentration of interleukin-6 (IL-6) or C-reactive protein (CRP), two routinely available markers of systemic inflammation in…”
Get full text
Journal Article -
6
Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis
Published in Annals of intensive care (19-05-2020)“…Background Bacterial infections are frequent triggers for diabetic ketoacidosis. In this context, delayed antibiotic treatment is associated with increased…”
Get full text
Journal Article -
7
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
Published in Frontiers in medicine (01-12-2022)“…Adrecizumab, a non-neutralizing antibody of adrenomedullin (ADM) was recently investigated regarding its potential to restore endothelial barrier function in…”
Get full text
Journal Article -
8
Combined coagulation and inflammation markers as predictors of venous thrombo-embolism and death in COVID-19
Published in Frontiers in medicine (10-06-2024)“…The COVID-19 pandemic related to SARS-CoV-2 virus was responsible for global pandemic. The severe form of the disease was linked to excessive activation of…”
Get full text
Journal Article -
9
Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire
Published in ESC Heart Failure (01-08-2023)“…Aims Acute heart failure (AHF) has an impact on human health worldwide. Despite guidelines for treatment and management of AHF, mortality rates remain high…”
Get full text
Journal Article -
10
Alterations in the Renin-Angiotensin System in Experimental Septic Shock
Published in Critical care explorations (01-10-2024)“…To analyze dynamic changes in the renin-angiotensin system (RAS) during septic shock, focusing on angiotensin-converting enzyme (ACE) activity and the balance…”
Get full text
Journal Article -
11
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
Published in Intensive care medicine experimental (07-06-2024)“…Background Dipeptidyl peptidase 3 (DPP3) is a ubiquitous cytosolic enzyme released into the bloodstream after tissue injury, that can degrade angiotensin II…”
Get full text
Journal Article -
12
Correction to: Early sepsis markers in patients admitted to intensive care unit with moderate‑to‑severe diabetic ketoacidosis
Published in Annals of intensive care (02-06-2020)“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text
Journal Article -
13
Immune-mediated thrombotic thrombocytopenic purpura: don’t miss the boat
Published in Intensive care medicine (01-02-2024)Get full text
Journal Article -
14
Should all patients with immune‐mediated thrombotic thrombocytopenic purpura receive caplacizumab?
Published in Journal of thrombosis and haemostasis (01-01-2021)“…Immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is a rare, life‐threatening disease that causes systemic platelet‐rich microthrombi with multiorgan…”
Get full text
Journal Article -
15
When targeted therapies alleviate the burden of TPE: The example of immune-mediated TTP
Published in Transfusion and apheresis science (01-06-2019)“…Thrombotic thrombocytopenic purpura is a rare and severe disease that manifests as a thrombotic microangiopathy with severe thrombocytopenia and variable…”
Get full text
Journal Article -
16
Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura
Published in Expert review of hematology (03-06-2019)“…: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a life-threatening disease characterized by a severe functional deficit in the von-Willebrand…”
Get more information
Journal Article -
17
Cardiac output drives tolerance of acute hemolysis
Published in Intensive care medicine (01-08-2018)Get full text
Journal Article -
18
SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanism
Published in Critical care (London, England) (23-11-2020)“…On day (D) 4, clinical deterioration with myoclonus worsening prompted the insertion of a left retrograde jugular catheter for brain oxygenation monitoring…”
Get full text
Journal Article -
19
Alteration of the Renin-Angiotensin-Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
Published in American journal of respiratory and critical care medicine (15-02-2021)Get full text
Journal Article -
20
Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides
Published in Hypertension (Dallas, Tex. 1979) (01-04-2024)“…High circulating DPP3 (dipeptidyl peptidase 3) has been associated with poor prognosis in critically ill patients with circulatory failure. In such situation,…”
Get full text
Journal Article